Table 5 Lipids and hepatic transaminases.

From: Vitamin D Supplementation in Overweight/obese Asian Indian Women with Prediabetes Reduces Glycemic Measures and Truncal Subcutaneous Fat: A 78 Weeks Randomized Placebo-Controlled Trial (PREVENT-WIN Trial)

Variables Week 0 Week 52 Week 78 Overall p value
(Between the groups)
Overall Effect Size (95% CI)
Using GEE Method
Intervention (n, 61) Placebo
(n, 60)
Intervention (n, 61) Placebo
(n, 60)
Intervention (n, 61) Placebo
(n, 60)
Serum TG (mg/dl) 144.1 ± 75.1 156.1 ± 60.6 135.5 ± 51.9 154.9 ± 54.0 135.5 ± 51.9 154.9 ± 54.0 0.67 4.3 (−16.4, 24.7)
TC (mg/dl) 182.1 ± 42.9 188.8 ± 43.5 180.9 ± 35.4 194.0 ± 39.0 175 ± 35.1 198.7 ± 36.4 0.49 −5.3 (−20.6, 9.9)
HDL (mg/dl) 41.9 ± 11.4 42.5 ± 11.8 44.8 ± 9.7 43.7 ± 10.8 44.8 ± 9.7 43.7 ± 10.8 0.92 −0.17 (−3.6, 3.3)
LDL (mg/dl) 112.3 ± 34.4 120.9 ± 30.9 116.8 ± 26.7 123.5 ± 27.4 116.8 ± 26.7 123.5 ± 27.4 0.49 −3.9 (−15.3, 7.4)
SGOT (IU/L) 26.4 ± 9.5 34.4 ± 26.3 23.1 ± 11.1 29.8 ± 25.0 23.1 ± 11.1 29.8 ± 25.0 0.14 −4.4 (−10.2, 1.5)
SGPT (IU/L) 16.5 ± 8.9 22.0 ± 17.8 17.0 ± 6.8 18.1 ± 9.1 17.0 ± 6.8 18.1 ± 9.1 0.38 −1.7 (−5.5, 2.1)
  1. Results are shown as mean ±  SD. p value < 0.05 is statistically significant. Effectiveness means that intention-to-treat analyses has been conducted. TG, triglycerides; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein, SGOT, serum glutamic pyruvic transaminase; SGPT; serum glutamic pyruvic transaminase; GEE, generalized estimating equation.